On Sept. 29, 2003, $81 million was awarded by National Institute of Allergy and Infectious Diseases (NIAID) through…
On Aug. 25, 2003, the FDA approved an expanded indication for ENBREL (etanercept) to inhibit the progression of…
On Jun. 20, 2003, Genentech drug Xolair (omalizumab) was approved by the U. S. Food and Drug Administration…
On Jun. 16, 2003, researchers at Stanford University Medical Center announced they found that a drug commonly prescribed…
On May 30, 2003, the Attorney General of California consented to the sale of the assets of the…
On May 22, 2003, Amgen announced it was relocating its cancer research division to Seattle following its acquisition…
On Apr. 27, 2003, Stanford researchers found that Wnt genes, first discovered as critical genes in cancer, are…
On Jan. 10, 2003, long-term efficacy and safety of etanercept (Enbrel) was found in children with polyarticular-course juvenile…
In 2003, The Institute for Collaborative Biotechnologies (ICB) was founded as an Army-sponsored University Affiliated Research Center (UARC)….
On Dec. 3, 2002, Genentech drug Pegasys (peginterferon alfa-2a) was approved by the Food and Drug Administration (FDA)…
On Aug. 5, 2002, President George W. Bush appointed Richard H. Carmona as U.S. Surgeon General, one of…
On Jul. 22, 2002, Amgen announced that the U.S. Food and Drug Administration (FDA) had approved Aranesp (darbepoetin…
On Jul. 16, 2002, Amgen completed it’s acquisition of Immunex Corporation for $16 billion in stock and net…
On Jul. 2, 2002, the University of California, Davis Comprehensive Cancer Center announced it had received National Cancer…
On Apr. 15, 2002, BOTOX(R) cosmetic (onabotulinumtoxinA), manufactured by Allergan, was approved by the Food and Drug Administration…
On Mar. 26, 2005, The University of Southern California/Norris Comprehensive Cancer Center in Los Angeles announced a $15…
In 2002, Stanford researchers became the first to use gene expression profiling to predict cancer outcomes. The research…
In 2002, the Nevada Cancer Institute (NVCI), founded in 2002 and located in Summerlin, was a non-profit organization…
On Dec. 17, 2001, the acquisition of Immunex by Amgen was announced for $16 billion in stock and…
On Nov. 19, 2001, researchers at Lucile Packard Children’s Hospital at Stanford announced they had identified a novel…
On Mar. 29, 2001, the Food and Drug Administration (FDA) announced it had approved Genentech’s drug Valcyte (valganciclovir…
On Jan. 10, 2001, Livermore National Laboratory announced a partnership with BioLuminate to develop ‘Smart Probe’ tool for…
In 1978, Moores Cancer Center (MCC) at UC San Diego achieved National Cancer Institute (NCI) designated comprehensive cancer…
On Dec. 16, 2002, researchers at Stanford University Medical Center announced they were continuing a multi-year clinical trial…
On Jul. 11, 2000, Stanford researchers announced they had identified a substance commonly added to toothpaste to prevent…
On June 2, 2000, the U.S. Food and Drug Administration announced it had approved Genentech’s drug TNKaseﾮ (tenecteplase)….
On Apr. 24, 2000, Stanford researchers announced they have solved the structure of the RNA polymerase protein, one…
In 2000, the University of California, Riverside Center for Nanoscale Science and Engineering was established to capitalize on…
On Jan. 10, 2012, the Norris Foundation made a $15 million commitment toward construction of the Harlyne J….
In 2000, the Center for Clinical Sciences Research building opened, and is an example of a fully integrated…